ChukyoiyakuhinCHUKYOIYAKUHIN CO.,LTD.4558東証スタンダード医薬品FY ending Mar 2026, non-consolidated, J-GAAP
Out of every ¥100 of sales, about ¥2 is left as operating profit. Revenue changed +4.2% from the prior year, operating profit +20.2%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 0.6% | 1.00× | 0.6% | 2.04× | 1.3% |
| 2023 | 0.3% | 1.08× | 0.3% | 2.04× | 0.6% |
| 2024 | — | —× | -0.5% | —× | — |
| 2025 | 0.7% | 1.24× | 0.9% | 2.04× | 1.8% |
| 2026 | 1.3% | 1.27× | 1.6% | 2.07× | 3.3% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 5,356 | 5,693 | 6,125 | 6,307 | 6,569 |
| Cost of revenue | 1,696 | 1,997 | 2,421 | 2,661 | 2,854 |
| Gross profit | 3,660 | 3,696 | 3,703 | 3,645 | 3,716 |
| SG&A | 3,596 | 3,636 | 3,575 | 3,539 | 3,588 |
| Operating income | 64 | 60 | 128 | 106 | 127 |
| Pretax income | 94 | 77 | 20 | 126 | 119 |
| Income tax | 61 | 63 | 48 | 81 | 35 |
| Net income attributable to owners | 33 | 14 | -27 | 45 | 84 |
| Operating margin | 1.2% | 1.0% | 2.1% | 1.7% | 1.9% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥1.29B | ¥944.9M | ¥949.4M | ¥1.08B | ¥956.7M |
| Total assets | ¥5.34B | ¥5.24B | ¥5.08B | ¥5.07B | ¥5.29B |
| Net assets | ¥2.62B | ¥2.58B | ¥2.52B | ¥2.53B | ¥2.58B |
| Share capital | ¥681M | ¥681M | ¥681M | ¥681M | ¥681M |
| Property, plant and equipment | ¥1.7B | ¥1.67B | ¥1.66B | ¥1.64B | ¥1.64B |
| Intangible assets excluding goodwill | ¥81.2M | ¥213M | ¥168.7M | ¥112.2M | ¥47.9M |
| Goodwill | ¥33.6M | ¥171.3M | ¥128.7M | ¥77.2M | ¥19M |
| Investment securities | ¥33.8M | ¥37.4M | ¥62.1M | ¥76.4M | ¥103.8M |
| Current assets | ¥3.16B | ¥2.95B | ¥2.81B | ¥2.92B | ¥3.11B |
| Current liabilities | ¥2.02B | ¥2.07B | ¥2.13B | ¥1.75B | ¥1.84B |
| Short-term borrowings | ¥910M | ¥830M | ¥970M | ¥750M | ¥760M |
| Long-term borrowings | ¥301.7M | ¥187.8M | ¥34.5M | ¥380M | ¥471.3M |
| Total liabilities | ¥2.72B | ¥2.66B | ¥2.56B | ¥2.54B | ¥2.71B |
| Equity attributable to owners of parent | ¥2.61B | ¥2.57B | ¥2.5B | ¥2.49B | ¥2.52B |
| Retained earnings | ¥1.71B | ¥1.67B | ¥1.59B | ¥1.58B | ¥1.61B |
| Treasury stock | -¥305.9M | -¥303.6M | -¥300.3M | -¥296.7M | -¥292M |
EDINET (FSA Japan)
有価証券報告書－第48期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第47期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第46期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第45期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第44期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第43期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 48 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.